If successful, menstrual bleeding will be reduced, but ablation does not shrink fibroids and will not relieve symptoms caused by the bulk or size of uterine fibroids
In one study, women with polycystic ovary syndrome were treated with 850 mg of metformin or a placebo twice daily for 6 months
Glow Blend combines three peptides with complementary mechanisms: GHK-Cu (copper tripeptide, collagen synthesis and matrix remodeling), BPC-157 (angiogenesis), and TB-500 (actin regulation, anti-fibrosis)
Most patients achieve best results starting conservatively at 200-250mcg daily and titrating gradually over 8-12 weeks to find their optimal maintenance dose, typically landing in the 250-350mcg range based on age, body composition, baseline IGF-1, and treatment goals